vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $140.7M, roughly 1.9× Purple Innovation, Inc.). Purple Innovation, Inc. runs the higher net margin — -2.3% vs -14.3%, a 12.0% gap on every dollar of revenue. On growth, Purple Innovation, Inc. posted the faster year-over-year revenue change (9.1% vs 4.7%). Enhabit, Inc. produced more free cash flow last quarter ($3.3M vs $-7.8M). Over the past eight quarters, Purple Innovation, Inc.'s revenue compounded faster (8.3% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
EHAB vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $140.7M |
| Net Profit | $-38.7M | $-3.2M |
| Gross Margin | — | 41.9% |
| Operating Margin | -12.3% | -1.6% |
| Net Margin | -14.3% | -2.3% |
| Revenue YoY | 4.7% | 9.1% |
| Net Profit YoY | 15.9% | 62.1% |
| EPS (diluted) | $-0.76 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $140.7M | ||
| Q3 25 | $263.6M | $118.8M | ||
| Q2 25 | $266.1M | $105.1M | ||
| Q1 25 | $259.9M | $104.2M | ||
| Q4 24 | $258.2M | $129.0M | ||
| Q3 24 | $253.6M | $118.6M | ||
| Q2 24 | $260.6M | $120.3M | ||
| Q1 24 | $262.4M | $120.0M |
| Q4 25 | $-38.7M | $-3.2M | ||
| Q3 25 | $11.1M | $-11.7M | ||
| Q2 25 | $5.2M | $-17.3M | ||
| Q1 25 | $17.8M | $-19.1M | ||
| Q4 24 | $-46.0M | $-8.5M | ||
| Q3 24 | $-110.2M | $-39.2M | ||
| Q2 24 | $-200.0K | $27.0K | ||
| Q1 24 | $200.0K | $-50.2M |
| Q4 25 | — | 41.9% | ||
| Q3 25 | — | 42.8% | ||
| Q2 25 | — | 35.9% | ||
| Q1 25 | — | 39.4% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | — | 29.7% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 34.8% |
| Q4 25 | -12.3% | -1.6% | ||
| Q3 25 | 6.4% | -10.2% | ||
| Q2 25 | 6.3% | -13.5% | ||
| Q1 25 | 6.1% | -13.9% | ||
| Q4 24 | -16.0% | -6.0% | ||
| Q3 24 | -38.6% | -39.5% | ||
| Q2 24 | 4.3% | -12.1% | ||
| Q1 24 | 4.9% | -19.3% |
| Q4 25 | -14.3% | -2.3% | ||
| Q3 25 | 4.2% | -9.9% | ||
| Q2 25 | 2.0% | -16.5% | ||
| Q1 25 | 6.8% | -18.4% | ||
| Q4 24 | -17.8% | -6.6% | ||
| Q3 24 | -43.5% | -33.1% | ||
| Q2 24 | -0.1% | 0.0% | ||
| Q1 24 | 0.1% | -41.8% |
| Q4 25 | $-0.76 | $0.03 | ||
| Q3 25 | $0.22 | $0.11 | ||
| Q2 25 | $0.10 | $0.16 | ||
| Q1 25 | $0.35 | $0.18 | ||
| Q4 24 | $-0.92 | $0.08 | ||
| Q3 24 | $-2.20 | $0.36 | ||
| Q2 24 | $0.00 | $0.00 | ||
| Q1 24 | $0.01 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $24.3M |
| Total DebtLower is stronger | $426.0M | $126.7M |
| Stockholders' EquityBook value | $534.0M | $-29.7M |
| Total Assets | $1.2B | $296.3M |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $24.3M | ||
| Q3 25 | $56.9M | $32.4M | ||
| Q2 25 | $37.1M | $34.2M | ||
| Q1 25 | $39.5M | $21.6M | ||
| Q4 24 | $28.4M | $29.0M | ||
| Q3 24 | $45.7M | $23.4M | ||
| Q2 24 | $28.5M | $23.4M | ||
| Q1 24 | $36.5M | $34.5M |
| Q4 25 | $426.0M | $126.7M | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | $70.7M | ||
| Q3 24 | $502.9M | $50.8M | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | — |
| Q4 25 | $534.0M | $-29.7M | ||
| Q3 25 | $566.8M | $-26.9M | ||
| Q2 25 | $552.4M | $-15.6M | ||
| Q1 25 | $543.2M | $1.3M | ||
| Q4 24 | $523.5M | $20.2M | ||
| Q3 24 | $566.1M | $28.0M | ||
| Q2 24 | $674.3M | $66.4M | ||
| Q1 24 | $672.3M | $65.5M |
| Q4 25 | $1.2B | $296.3M | ||
| Q3 25 | $1.2B | $302.1M | ||
| Q2 25 | $1.2B | $303.8M | ||
| Q1 25 | $1.2B | $293.8M | ||
| Q4 24 | $1.2B | $307.8M | ||
| Q3 24 | $1.3B | $309.3M | ||
| Q2 24 | $1.4B | $362.1M | ||
| Q1 24 | $1.4B | $382.1M |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | 3.50× | ||
| Q3 24 | 0.89× | 1.82× | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-5.8M |
| Free Cash FlowOCF − Capex | $3.3M | $-7.8M |
| FCF MarginFCF / Revenue | 1.2% | -5.5% |
| Capex IntensityCapex / Revenue | 0.4% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $-5.8M | ||
| Q3 25 | $37.8M | $-968.0K | ||
| Q2 25 | $10.6M | $-4.0M | ||
| Q1 25 | $17.9M | $-23.1M | ||
| Q4 24 | $-4.1M | $6.8M | ||
| Q3 24 | $28.4M | $1.1M | ||
| Q2 24 | $9.6M | $-8.9M | ||
| Q1 24 | $17.3M | $-16.8M |
| Q4 25 | $3.3M | $-7.8M | ||
| Q3 25 | $36.2M | $-1.8M | ||
| Q2 25 | $8.7M | $-7.0M | ||
| Q1 25 | $17.6M | $-25.3M | ||
| Q4 24 | $-4.7M | $5.7M | ||
| Q3 24 | $27.7M | $101.0K | ||
| Q2 24 | $8.9M | $-11.0M | ||
| Q1 24 | $15.5M | $-19.9M |
| Q4 25 | 1.2% | -5.5% | ||
| Q3 25 | 13.7% | -1.5% | ||
| Q2 25 | 3.3% | -6.6% | ||
| Q1 25 | 6.8% | -24.3% | ||
| Q4 24 | -1.8% | 4.4% | ||
| Q3 24 | 10.9% | 0.1% | ||
| Q2 24 | 3.4% | -9.2% | ||
| Q1 24 | 5.9% | -16.5% |
| Q4 25 | 0.4% | 1.4% | ||
| Q3 25 | 0.6% | 0.7% | ||
| Q2 25 | 0.7% | 2.8% | ||
| Q1 25 | 0.1% | 2.2% | ||
| Q4 24 | 0.2% | 0.8% | ||
| Q3 24 | 0.3% | 0.9% | ||
| Q2 24 | 0.3% | 1.7% | ||
| Q1 24 | 0.7% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | 3.41× | — | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | 86.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
